Healthcare provider profile · identity verified

Sharon M. Hammond, MD

Family Practice · ASHLAND, WI · NPI 1962453829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	281	64
Lisinopril	Lisinopril	220	62
Levothyroxine Sodium	Levothyroxine Sodium	209	47
Losartan Potassium	Losartan Potassium	209	47
Metoprolol Succinate	Metoprolol Succinate	180	52
Omeprazole	Omeprazole	178	43
Amlodipine Besylate	Amlodipine Besylate	169	44
Hydrochlorothiazide	Hydrochlorothiazide	167	48
Furosemide	Furosemide	161	29
Gabapentin	Gabapentin	151	28
Simvastatin	Simvastatin	126	35
Rosuvastatin Calcium	Rosuvastatin Calcium	125	32
Metoprolol Tartrate	Metoprolol Tartrate	109	22
Pantoprazole Sodium	Pantoprazole Sodium	103	24
Eliquis	Apixaban	102	14
Lorazepam	Lorazepam	95	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	20
Tramadol Hcl	Tramadol Hcl	93	15
Metformin Hcl	Metformin Hcl	89	18
Escitalopram Oxalate	Escitalopram Oxalate	83	25
Bupropion Xl	Bupropion Hcl	82	17
Allopurinol	Allopurinol	81	12
Trazodone Hcl	Trazodone Hcl	72	16
Sertraline Hcl	Sertraline Hcl	68	15
Albuterol Sulfate Hfa	Albuterol Sulfate	63	28
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	55	11
Pregabalin	Pregabalin	54	14
Carvedilol	Carvedilol	53	13
Metformin Hcl Er	Metformin Hcl	53	13
Fluticasone Propionate	Fluticasone Propionate	51	12
Aripiprazole	Aripiprazole	50	suppressed
Baclofen	Baclofen	49	suppressed
Ozempic	Semaglutide	49	suppressed
Potassium Chloride	Potassium Chloride	49	15
Fluoxetine Hcl	Fluoxetine Hcl	48	13
Clopidogrel	Clopidogrel Bisulfate	41	11
Meloxicam	Meloxicam	40	15
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Warfarin Sodium	Warfarin Sodium	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Estradiol	Estradiol	33	15
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Glipizide Er	Glipizide	30	suppressed
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Atenolol	Atenolol	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Finasteride	Finasteride	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	24	suppressed
Valsartan	Valsartan	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Clotrimazole	Clotrimazole	21	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Fosinopril Sodium	Fosinopril Sodium	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Fluconazole	Fluconazole	17	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Naproxen	Naproxen	17	suppressed
Prednisone	Prednisone	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Nystatin	Nystatin	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error